Quantum Computing boost for Cambridge with input from South Korea

19 Nov, 2025
Tony Quested
Cambridge has taken a further globally significant step in the field of quantum computing. The Milner Therapeutics Institute in the city, spearheaded by Professor Sir Tony Kouzarides, has stepped on the gas with a new initiative, we can exclusively reveal.
Thumbnail
Professor Sir Tony Kouzarides. Photograph by Phil Mynott.

Sir Tony tells Business Weekly that the Milner Therapeutics Institute (MTI) has set up a Quantum Computing Unit at the Milner, in collaboration with Yonsei University in South Korea.

He said: “Our collaboration will allow us full access to their IBM System One Quantum Computer – South Korea’s first and only on-site superconducting quantum system. It will be used to probe healthcare issues such as target ID and drug discovery.”

Sir Tony is director and co-founder of the Milner Institute and group leader at the Gurdon Institute at the University of Cambridge.

Cambridge is already home to a world leader in QC in Quantinuum, which is forging ahead locally and in the US, and to the Wellcome Sanger Institute which is using quantum computing for a phase of its genomics research.

The Milner Institute on the biomedical campus provides a physical hub that combines the strength of academia and business to accelerate the development of therapies. Its research teams focus on the development of human models of disease and the use of gene editing to better understand how diseases arise, and the application of artificial intelligence and quantum computing to interrogate large patient and human tissue-based datasets.

Yonsei is one of the three most prestigious universities in South Korea, part of a group referred to as SKY universities.

We reported in July that a collaboration between the Wellcome Sanger Institute and the Universities of Oxford and Cambridge in the UK plus Melbourne, with Kyiv Academic University as an additional partner, had progressed into the final stage of the Q4Bio Challenge, a competitive research programme funded by Wellcome Leap.

And in August we revealed that the Wellcome Sanger Institute had chosen Quantinuum's quantum computer option to explore fresh solutions in complex genomics.

Sir Tony has been working for months on advancing the cause of quantum computing from the MTI as a springboard for international life science and DeepTech growth.

Another Cambridge company, Riverlane – global leader in quantum error correction – recently launched its Deltakit software platform which enables quantum developers to learn, develop, and, ultimately, adopt real-time QEC on the world’s leading quantum computers.

Fellow University of Cambridge spin-out Nu Quantum is making good progress with its Quantum Networking Unit – designed to entangle a cluster of four trapped-ion quantum processors.